SCHEMBL19917239

SCHEMBL19917239

COc1cccc(-c2ccc3c(O)c(C(=O)NCC(=O)N=O)ncc3n2)c1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 9/20 0.50
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
KDM4E B2RXH2 2/20 0.41
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MAPT P10636 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
PRKDC P78527 1/20 0.41
ATR Q13535 1/20 0.41
THRA P10827 3/20 0.41
THRB P10828 3/20 0.41
EGLN2 Q96KS0 3/20 0.41
ROCK2 O75116 1/20 0.40
ROCK1 Q13464 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20109775 0.91 EGLN1 (0.62) EGLN1THRATHRB
SCHEMBL19895189 0.83 MAPT (0.47) MEN1KMT2AKDM4ESMN1; SMN2MAPT
SCHEMBL22369521 0.79 EGLN1 (0.51) EGLN1MEN1KMT2AEGLN2
SCHEMBL20109769 0.79 EGLN1 (0.60) EGLN1THRATHRBEGLN2
SCHEMBL19917277 0.78 EGLN1 (0.61) EGLN1KDM4ELMNATHRATHRB
SCHEMBL18121919 0.78 FTO (0.53) EGLN1MEN1KMT2AKDM4EEGLN2
SCHEMBL20109767 0.76 EGLN1 (0.57) EGLN1LMNATHRATHRB
SCHEMBL20109771 0.76 EGLN1 (0.62) EGLN1EGLN2
SCHEMBL20109766 0.76 EGLN1 (0.61) EGLN1THRATHRB
SCHEMBL19917243 0.76 EGLN1 (0.52) EGLN1THRATHRBEGLN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3287456-A1 COMPOUND OF 5-HYDROXYL-1,7-NAPHTHYRIDINE SUBSTITUTED BY ARYL OR HETEROARYL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE THEREOF Shenyang Sunshine Pharmaceutical Co., Ltd. (CN) 2018-02-28 EP disclosed